Analysts have clear opinions on ZBH.

There are 19 analysts on the Wall offering 12 month price targets for Zimmer Biomet Holdings in the last 3 months. The average price target is $171.72 with a high forecast of $190.00 and a low forecast of $125.00. The average price target represents a 8.20% increase from the last price of $158.70.
Zimmer Biomet Holdings, Inc. (ZBH) is followed by 19 analysts on the street.

David Turkaly from JMP Securities rates it a Buy with a target of $175.00.

Similarly, 7 days ago Matt Miksic of Credit Suisse Reiterated a Sell with a target of $125.00.

The consensus on the street is null.

What does Zimmer Biomet Holdings, Inc.(ZBH) do ?
Zimmer Biomet Holdings, Inc. provides musculoskeletal healthcare services. It designs, manufactures and markets orthopedic reconstructive products, sports medicine, biologics, extremities & trauma products, office based technologies, spine, craniomaxillofacial & thoracic products, dental implants and related surgical products. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Zimmer Biomet Holdings was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.

Zimmer Biomet Holdings, Inc. (ZBH) Insider Trades

Multiple company employees have indulged in significant insider trading. Zimmer Biomet Holdings, Inc. disclosed the following in a document filed with the US Securities and Exchange Commission (SEC):

Group Pres, Bruneau Aure : S – Sale+OE(-$2,142,866) of ZBH in the trading session of 2019-11-11.

Pres, EMEA Deltort Didier : S – Sale(-$61,925) of ZBH in the trading session of 2019-09-06.

SVP, GC, Secretary Phipps Chad F : S – Sale(-$967,932) of Zimmer Biomet Holdings, Inc. in the trading session of 2019-08-29.

Looking for stocks just like ZBH?

Based on Wall Street analyst research, several stocks are similar to ZBH
They are:
– SYK [Info can be found here: ]
– NUVA [Info can be found here: ]
– GMED [Info can be found here: ]